BOTHELL, WA and VANCOUVER, Aug. 13 / OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ), today announced that the first patient has been dosed in an open label, dose-escalation, Phase 1 clinical trial evaluating OGX-427 when administered directly into the bladder in patients with bladder cancer. This trial is separate from an ongoing Phase 1 trial of OGX-427 administere... 
As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial ...
SpineUniverse, a Vertical Health website, proudly introduces the Community Case Discussion for its network of spine professionals. This interactive forum allows spine specialists to engage with one another in the SpineUniverse Spinal Case Study Library.
damaka supports multiple mobile platforms (Smartphones) on different wireless broadband networks. Richardson, Texas (PRWEB) March 12, 2010 – damaka, ...
Researchers at Oregon Health & Science University's School of Dentistry (www.ohsu.edu/sod) have discovered that nitric oxide is a powerful regulator of a molecule that plays a critical role in the development and function of the nervous system. The finding could someday play a significant role in the prevention and treatment ...
bdnf, blood, play, pressure, prevention, significant, someday, study
French medical researchers from the AP-HP (Henri Mondor Hospital and Avicenne Hospital) and Inserm (Unit 738 "Models and methods for therapeutic evaluation of chronic illnesses" and CIC 202, at Tours) have recently demonstrated the effectiveness of a new molecule in the fight against lice. Faced with the emergence of increasing ...
UCB today announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia.
Replaying recent events in the area of the brain called the hippocampus may have less to do with creating long-term memories, as scientists have suspected, than with an active decision-making process, suggests a new study by researchers at Carnegie Mellon University and the University of Minnesota Medical School.
